Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway. - barrons.com
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway. - barrons.com
Business
18 hours ago 114 Views 05 Comment 1.5k Share
Listen to this article
0%
Pfizerlifted the bottom end of its full-year revenue guidance on Tuesday, citing growth in its non-Covid pharmaceutical portfolio. Its smaller Covid vaccine partner offered a less optimistic outlook.… [+99 chars]